The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis
about
Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapyRecent advances in understanding idiopathic pulmonary fibrosisPharmacological management of IPFIdiopathic pulmonary fibrosis: Diagnosis, epidemiology and natural historyUnderstanding Idiopathic Interstitial Pneumonia: A Gene-Based Review of Stressed LungsMolecular classification of idiopathic pulmonary fibrosis: personalized medicine, genetics and biomarkersViruses in Idiopathic Pulmonary Fibrosis. Etiology and ExacerbationThe peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processesPrecision Medicine: The New Frontier in Idiopathic Pulmonary FibrosisThe development of lower respiratory tract microbiome in miceThe respiratory microbiome in idiopathic pulmonary fibrosis.Lung microbiome and host immune tone in subjects with idiopathic pulmonary fibrosis treated with inhaled interferon-γ.The bacterial microbiota in inflammatory lung diseasesThe Lung Microbiome: New Principles for Respiratory Bacteriology in Health and Disease.Lungs, microbes and the developing neonate.The Microbiome and the Respiratory TractSurvival in Idiopathic pulmonary fibrosis acute exacerbations: the non-steroid approach.Efficacy of concurrent treatments in idiopathic pulmonary fibrosis patients with a rapid progression of respiratory failure: an analysis of a national administrative database in Japan.Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF.Data Mining of Lung Microbiota in Cystic Fibrosis Patients.Clinical Features and Outcomes of IPF Patients Hospitalized for Pulmonary Infection: A Japanese Cohort Study.Bronchial microbiome, PA biofilm-forming capacity and exacerbation in severe COPD patients colonized by P. aeruginosa.MUC5B and Idiopathic Pulmonary Fibrosis.TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary FibrosisIdiopathic Pulmonary Fibrosis: Novel Concepts of Proton Pump Inhibitors as Antifibrotic Drugs.Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis.CT Imaging Phenotypes of Pulmonary Fibrosis in the MUC5B Promoter Site PolymorphismAssociation Between the MUC5B Promoter Polymorphism rs35705950 and Idiopathic Pulmonary Fibrosis: A Meta-analysis and Trial Sequential Analysis in Caucasian and Asian Populations.Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary Fibrosis.Sepsis risk factors in infants with congenital diaphragmatic hernia.Calpain 1 regulates TGF-β1-induced epithelial-mesenchymal transition in human lung epithelial cells via PI3K/Akt signaling pathway.Acute exacerbation of idiopathic pulmonary fibrosis-a review of current and novel pharmacotherapiesInflammatory response mechanisms exacerbating hypoxemia in coexistent pulmonary fibrosis and sleep apnea.The Lung Immune Response to Nontypeable Haemophilus influenzae (Lung Immunity to NTHi).Update in Interstitial Lung Disease 2014.Nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease: a review for clinicians.Respiratory microbiota and lower respiratory tract disease.Microbiome in interstitial lung disease: from pathogenesis to treatment target.Novel Drug Targets For Idiopathic Pulmonary Fibrosis.
P2860
Q26738458-0C259710-DF41-4126-AEE8-C89E81E379ECQ26745905-A4FA5C1E-0E7F-4542-8E9F-518308A921E9Q26748808-82C975CB-FE7D-46A5-B0A9-CF1B394852C0Q26776473-E62AF436-8064-4A99-A720-9C2664567A15Q26779192-67FC5777-C592-47FC-8E4C-B83726D90B63Q26864836-D1739AE5-1C32-4158-B8AD-D6E9CBB3026EQ28081676-A594E2AB-5111-4A06-A33F-C6005701957CQ33601748-B4345398-9F64-4EA2-93A4-4BE0DE33F3C3Q33714064-92853AC4-DFD1-436B-9A77-D08C364E33E2Q33820414-B693BEBD-1125-4CF1-839E-931AF2F5E031Q33871544-12E23A2F-D542-4AB2-A2D0-CB888355F1CEQ33897430-91520528-2242-46AE-9E1F-1CE4E127437BQ35677622-A32F86A6-2521-40B6-9B45-86044F4F9126Q35687192-F6DF3FCA-B69D-48E1-8AFC-87DC63198C05Q35736479-D59C0197-66AE-46B6-A183-CF21A244A57EQ35829947-033F32A5-905B-4208-B92B-F79CEF3056B9Q35868426-79FAA82F-E465-4644-A3C8-C5EEF8F8877CQ36045589-2620F116-47FA-4AD8-B229-EC46C99BC62BQ36095068-5ED66173-7901-4D0C-A614-7658F13C95A5Q36163849-84BB03C1-3DCB-471D-B069-2E1EC4D44371Q36222034-3F172844-F613-4FD4-89CE-348ED51AAD3CQ36321964-46162D55-C5C0-400F-978E-305BD50607D9Q36490141-86060F9F-4162-4B12-9EF7-645872C65754Q36516894-C9042D43-618D-4184-A6EB-F47EACA44844Q37013159-AD76904F-1175-478A-A8B6-3EF00A985F82Q37080510-503D0BB7-A0B8-44AA-8F4E-5614A14F578BQ37085155-55B70E85-6E0D-44EF-A5BE-92ED397D444AQ37094624-57C353B2-9BC1-4CBE-9561-46D938152B3CQ37149994-C53C36A1-8A55-4E08-9E6D-EEAE1D629BBAQ37345980-8B2BA6B6-9695-4094-A4E7-12611F816325Q37712548-B7507019-5403-4117-B32A-8C00FA5CB3A0Q37733049-AC2E712E-F0FC-4313-9702-1DA1F70809BDQ38448525-2D40FAFB-0ABD-4700-A488-B327E5005AD6Q38461691-B75A5E6F-C153-4837-B664-991C5E0E5E8FQ38538384-6B6F8C22-3D87-4499-8678-EA41204944A1Q38631673-AC4E2CBC-90CB-47F5-8B09-611B9BB92E00Q38679715-FB0AEF80-EB00-45B7-A664-D497E6F2D1F5Q38702812-901C8791-D823-42CF-B99B-9E2D219DE0C0Q38708801-CA69BC00-460F-4D5F-9CE7-A366D37DB5BCQ38725808-64FF902F-A924-44AE-B02F-A47103E998E4
P2860
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis
@ast
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis
@en
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis
@nl
type
label
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis
@ast
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis
@en
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis
@nl
prefLabel
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis
@ast
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis
@en
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis
@nl
P2093
P2860
P50
P1476
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis
@en
P2093
Anne-Marie Russell
Athol U Wells
David A Schwartz
Elissa Murphy
Kirsty E Russell
Miriam F Moffatt
Patrick Mallia
Phillip L Molyneaux
Saffron A G Willis-Owen
William O C Cookson
P2860
P304
P356
10.1164/RCCM.201403-0541OC
P407
P577
2014-10-01T00:00:00Z